DK0649430T3 - Derivater af 16-leddede, antibiotiske ringmakrolider - Google Patents

Derivater af 16-leddede, antibiotiske ringmakrolider

Info

Publication number
DK0649430T3
DK0649430T3 DK93914300.4T DK93914300T DK0649430T3 DK 0649430 T3 DK0649430 T3 DK 0649430T3 DK 93914300 T DK93914300 T DK 93914300T DK 0649430 T3 DK0649430 T3 DK 0649430T3
Authority
DK
Denmark
Prior art keywords
derivatives
pct
membered
animals
sec
Prior art date
Application number
DK93914300.4T
Other languages
Danish (da)
English (en)
Inventor
James W Mcfarland
Scott J Hecker
Martin R Jefson
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of DK0649430T3 publication Critical patent/DK0649430T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Radiation-Therapy Devices (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK93914300.4T 1992-07-15 1993-06-07 Derivater af 16-leddede, antibiotiske ringmakrolider DK0649430T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US91424292A 1992-07-15 1992-07-15
US99624392A 1992-12-23 1992-12-23

Publications (1)

Publication Number Publication Date
DK0649430T3 true DK0649430T3 (da) 1998-02-09

Family

ID=27129638

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93914300.4T DK0649430T3 (da) 1992-07-15 1993-06-07 Derivater af 16-leddede, antibiotiske ringmakrolider

Country Status (22)

Country Link
US (1) US5545624A (tr)
EP (1) EP0649430B1 (tr)
JP (1) JP2836964B2 (tr)
KR (1) KR950702570A (tr)
CN (1) CN1083068A (tr)
AT (1) ATE161265T1 (tr)
AU (1) AU4401093A (tr)
BR (1) BR9306741A (tr)
CA (1) CA2140243A1 (tr)
CZ (1) CZ9995A3 (tr)
DE (1) DE69315839T2 (tr)
DK (1) DK0649430T3 (tr)
FI (1) FI933204A (tr)
GR (1) GR3026064T3 (tr)
HU (1) HUT65330A (tr)
IL (1) IL106263A0 (tr)
MX (1) MX9304301A (tr)
PL (1) PL307137A1 (tr)
SK (1) SK4795A3 (tr)
TW (1) TW226373B (tr)
UY (1) UY23617A1 (tr)
WO (1) WO1994002496A1 (tr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5677287A (en) * 1993-03-18 1997-10-14 Pfizer Inc. Antibacterial 16-membered ring macrolides containing olefins at C-20
DE69402714T2 (de) * 1993-07-15 1997-07-31 Pfizer Amid-derivate von 16-gliedrige heterocyclen als antibiotische macrolide
ES2076107B1 (es) * 1993-09-20 1996-04-01 Pfizer Derivados de antibioticos macrolidos de anillos de 16 miembros.
WO1996009312A1 (en) * 1994-09-22 1996-03-28 Pfizer Inc. Antibiotic macrolides
EP0778283A3 (en) * 1995-12-05 1998-01-28 Pfizer Inc. Antibiotic macrolides
US6605599B1 (en) 1997-07-08 2003-08-12 Bristol-Myers Squibb Company Epothilone derivatives
ATE261450T1 (de) * 1999-08-30 2004-03-15 Zaidan Hojin Biseibutsu Makrolid-antibiotika und behandlung von pasteurellosis
US20020128213A1 (en) * 2000-09-25 2002-09-12 Leonard Katz Sixteen-membered macrolide compounds
US6664240B2 (en) * 2001-11-15 2003-12-16 Enanta Pharmaceuticals, Inc. Tylosin derivatives having antibacterial activity
DE60330651D1 (en) 2002-03-12 2010-02-04 Bristol Myers Squibb Co C3-cyanoepothilonderivate
US7247617B2 (en) * 2004-07-13 2007-07-24 Kosan Biosciences Incorporated Sixteen-member macrolide antiinfective agents
WO2008012343A2 (en) 2006-07-28 2008-01-31 Intervet International B.V. Macrolide synthesis process
UA98303C2 (ru) * 2006-07-28 2012-05-10 Интервет Интернешонал Б.В. Способ синтеза макролидов
SI2782922T1 (en) 2011-11-25 2018-05-31 Bayer Intellectual Property Gmbh ANTIBACTERIAL TYLOSINE DERIVATIVES AND PREPARATION PROCEDURES
FR2995605B1 (fr) * 2012-09-18 2014-09-19 Sanofi Sa Derives de macrolides, leur preparation et leur application therapeutique.
MY184630A (en) * 2013-05-23 2021-04-11 Bayer Animal Health Gmbh Tylosin derivatives and method for preparation thereof
CN104788519B (zh) * 2014-01-22 2018-07-20 镇江威特药业有限责任公司 十六元环三胺内酯衍生物及其应用
CN105777828A (zh) * 2014-12-22 2016-07-20 菏泽市方明制药有限公司 一种用低质量的泰乐菌素制备高质量替米考星的方法
US10287275B2 (en) 2015-04-16 2019-05-14 Victor Pharma Co., Ltd. Zhenjiang 16-member triamilide derivatives and uses thereof
CN117510561B (zh) * 2023-11-30 2024-04-02 中国农业科学院饲料研究所 一种泰乐菌素衍生物及其制备方法与应用
CN117304241B (zh) * 2023-11-30 2024-03-01 中国农业科学院饲料研究所 一种大环内酯类化合物及其制备方法与应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3975372A (en) * 1975-02-28 1976-08-17 Schering Corporation Preparation of 12,13-desepoxy-12,13-dehydrorosamicin
IL69666A (en) * 1982-09-13 1987-10-20 Lilly Co Eli 20-amino-20-deoxo-5-o-mycaminosyl-23-o-mycinosyltylonolide derivatives,their preparation and veterinary antibiotic use
US4443436A (en) * 1982-09-13 1984-04-17 Eli Lilly And Company C-20-Modified macrolide derivatives of the macrolide antibiotics tylosin, desmycosin, macrocin, and lactenocin
JPS59225199A (ja) * 1983-02-10 1984-12-18 Microbial Chem Res Found ２０，２３−ジデオキシ−２３−アルキレンイミノ−２０−置換アミノマイカミノシルレロノライド
IL71032A0 (en) * 1983-02-28 1984-05-31 Lilly Co Eli C-20 and c-23-modified macrolide derivatives
US4468511A (en) * 1983-02-28 1984-08-28 Eli Lilly And Company C-20- And C-23-Modified macrolide derivatives
JPS59181299A (ja) * 1983-03-31 1984-10-15 Microbial Chem Res Found ２０，２３−ジデオキシ−２０，２３−ビス置換アミノ−マイカミノシルレロノライド
US4921947A (en) * 1986-03-31 1990-05-01 Eli Lilly And Company Process for preparing macrolide derivatives
US4920103A (en) * 1986-09-29 1990-04-24 Eli Lilly And Company Modifications of mycinose and 3-O-demethylmycinose in tylosin-type macrolides
EP0262903A3 (en) * 1986-09-29 1988-11-02 Eli Lilly And Company New acyl derivatives of 20-modified tylosin and desmycosin compounds
US4820694A (en) * 1986-09-29 1989-04-11 Eli Lilly And Company Modifications of 3-O-demethylmycinose in macrocin and lactenocin
FR2638458A1 (fr) * 1988-10-27 1990-05-04 Adir Nouveaux derives de la tylosine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
CZ9995A3 (en) 1995-07-12
DE69315839T2 (de) 1998-04-09
AU4401093A (en) 1994-02-14
CN1083068A (zh) 1994-03-02
MX9304301A (es) 1994-02-28
TW226373B (tr) 1994-07-11
BR9306741A (pt) 1998-12-08
DE69315839D1 (de) 1998-01-29
HUT65330A (en) 1994-05-02
UY23617A1 (es) 1994-01-05
US5545624A (en) 1996-08-13
ATE161265T1 (de) 1998-01-15
GR3026064T3 (en) 1998-05-29
JP2836964B2 (ja) 1998-12-14
WO1994002496A1 (en) 1994-02-03
PL307137A1 (en) 1995-05-02
FI933204A (fi) 1994-01-16
JPH07504922A (ja) 1995-06-01
HU9302016D0 (en) 1993-10-28
SK4795A3 (en) 1995-07-11
FI933204A0 (fi) 1993-07-14
EP0649430B1 (en) 1997-12-17
CA2140243A1 (en) 1994-02-03
EP0649430A1 (en) 1995-04-26
KR950702570A (ko) 1995-07-29
IL106263A0 (en) 1993-11-15

Similar Documents

Publication Publication Date Title
DK0649430T3 (da) Derivater af 16-leddede, antibiotiske ringmakrolider
ATE151767T1 (de) Amid-derivate von 16-gliedrige heterocyclen als antibiotische macrolide
AP9801253A0 (en) 9-Oxime erythromycin derivatives.
NZ335825A (en) Use of azithromycin for treating atherosclerosis
HUP0004579A2 (hu) Antibakteriális hatású, a 3'-N-pozícióban módosított szerkezetű 6-0-szubsztituált-eritromicin-ketolid-származékok és ezeket tartalmazó gyógyszerkészítmények
PT1161438E (pt) Macrolidos 6-o-substituidos com actividade antibacteriana
PT1042340E (pt) Oxima de 6-o-alquil-eritromicina b
PT876388E (pt) Derivados de eritromicina triciclica
DK0808326T3 (da) Basiske oxazolinamidderivater af GE2270 og GE2270-lignende antibiotika
MD970243A (en) 9-O-Oximes erythromycin A derivatives, possessing antibiotic properties
MX9606111A (es) Antibioticos macrolidos.
BG106123A (en) Diphosphate salt of a 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin derivative and its pharmaceutical composition
NO950143L (no) Derivater av antibiotiske makrolider med 16-leddet ring
PL324884A1 (en) Application of prostane derivatives and their compositions with antibiotics in treating bacterial infections
ES2191778T3 (es) Derivados de 3-desoxi-3-descladinosa de las eritromicinas a y b.